TopoDx

TopoDx is developing an interferometry-driven diagnostic that delivers culture-free pathogen identification and antimicrobial-susceptibility results in under four hours. Its flagship Cosmos Platform pairs a benchtop detector, proprietary interferometric plates, and integrated AI to transform real-time bacterial topography into resistance profiles, enabling clinicians to target therapy on day one. By shortening time-to-effective treatment, TopoDx aims to curb antibiotic misuse, improve outcomes, and lower hospital costs.